|
51 |
Message from Hon'ble Minister (C&F) on Swachhta Pakhwada During 1-15 September 2024 |
|
|
52 |
Message from Hon'ble MoS (C&F) on Swachhta Pakhwada During 1-15 September 2024 |
|
|
53 |
Standing Order - Circular No. 2 of 2024 under UCPMP-2024 |
|
|
54 |
Additional charge of the post of Chairman, National Pharmaceuticals Pricing Authority (NPPA) assigned to Shri Arunish Chawla, Secretary, Department of Pharmaceuticals |
|
|
55 |
Corrigendum (date & technical) Regarding Tender for Selection of Consulting Firm for strategy development and implementation of the Promotion of Research and Innovation in Pharma MedTech (PRIP) Sector Scheme. |
|
|
56 |
Invitation for a pre-bid meeting regarding Tender for Selection of Consulting Firm for strategy development and implementation of the Promotion of Research and Innovation in Pharma MedTech (PRIP) Sector Scheme - Reg. |
|
|
57 |
Study report on Bridging Academia-Industry Gap to achieve Self-reliance |
|
|
58 |
Study Report on Impact of the Drug Price Control Order (DPCO) 2013 on the price of Cardiac stents Knee implants and six medical devices on industry and consumers in terms of availability and affordability |
|
|
59 |
Standing Order- Circular No. 1 of 2024 under UCPMP-2024 |
|
|
60 |
Recruitment of Young Professionals on contract basis in Department of Pharmaceuticals- reg. |
|
|
61 |
Advertisement for engagement of Young Professionals (2), Junior Consultant (1), Senior Consultant (1) for Project Management Unit of PRIP Scheme. |
|
|
62 |
Term of Reference for Hiring of Young Professionals (2), Junior Consultant (1), Senior Consultant (1) for Project Management Unit of PRIP Scheme |
|
|
63 |
Recruitment of Young Professionals on contract basis in Department of Pharmaceuticals- reg. |
|
|
64 |
Revised Guidelines for the Scheme - Strengthening of Pharmaceuticals Industry (SPI), Dated 14th March 2024. |
|
|
65 |
Study report on An analysis on leveraging the patent cliff, with drug sales worth USD 251 billion going off-patent and to analyses the different drug pricing methodologies particularly w.r.t. these patented drugs going off-patent |
|
|
66 |
Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024 - reg |
|
|
67 |
Public Notice dated 12.03.2024: Inviting details of local manufacturers of Medical Devices |
|
|
68 |
Modifications in the guidelines of Production Linked Incentive (PLI) Scheme for promotion of domestic manufacturing of critical Key Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients (APIs) in the country (PLI BD)- reg |
|
|
69 |
Modifications in the guidelines of Production Linked Incentive scheme for Promoting Domestic Manufacturing of Medical Devices (PLI MD) relating to revision of Scheduled Commercial Operation Date (SCOD) and invocation of bank guarantee - reg |
|
|
70 |
Constitution of a Committee for Reforms in the Pricing Framework for Drugs and Medical Devices. |
|
|
71 |
Modifications/ Clarifications in the Operational Guidelines for the Production Linked Incentive (PU) Scheme for Pharmaceuticals - Dated 11th March, 2024 |
|
|
72 |
Guidelines for the Scheme (Strengthening of Pharmaceuticals Industry (SPI)) - Revamping of the PTUAS sub-scheme and Notification of the modification in the guidelines - reg. |
|
|
73 |
Public Notice dated 08.03.2024: Inviting details of local manufacturers of specific Drugs/Medicines/Pharmaceutical Formulations |
|
|
74 |
Invitation of applications under the Scheme Assistance to Medical Device Clusters for Common Facilities (AMD-CF)-regarding. |
|
|
75 |
Result of Consultant's interview |
|
|
76 |
Examination Call letter for Young Professionals |
|
|
77 |
Extension of Timeline for Invitation of Applications from eligible category B Applicants under the revised guidelines of PLI - Medical Devices till 29.02.2024- reg |
|
|
78 |
Notice for Invitation of applications under the Scheme 'Assistance to Medical Device Clusters for Common Facilities' (AMD-CF)-regarding. |
|
|
79 |
Study on Upgrading NIPERs to meet evolving needs of Pharmaceutical business and NIPERs in top 50 in world ranking |
|
|
80 |
Eligible/ineligible candidates for the post of Consultant. |
|
|
81 |
Modifications in the guidelines of Production Linked Incentive (PLI) Scheme for promoting domestic manufacturing of Medical Devices (PLI - MD) to invite applications for the eligible products as per Annexure-1A for Category-B applicant dated 19.12.2023 |
|
|
82 |
Invitation of applications from eligible Category-B applicants for 30 days under the corrigendum/addendum dated 19/12/2023 read with the revised guidelines of PLI scheme for promoting domestic manufacturing of the Medical Devices dated 25.02.2023- reg. |
|
|
83 |
Constitution Day Celebrations -reg |
|
|
84 |
Study on CRO Sector in India |
|
|
85 |
Revision of Fellowship for PhD Scholars of NIPERs |
|
|
86 |
Notice for Extension of date for the Request for Proposal for the Promotion of Research and Innovation in Pharma and MedTech Sector (PRIP) Scheme. |
|
|
87 |
Approach Paper on Draft National Pharmaceuticals Policy 2023 for stakeholder consultation |
|
|
88 |
Notice for Extension of date for the Request for Proposal for the Promotion of Research and Innovation in Pharma and MedTech Sector (PRIP) Scheme. |
|
|
89 |
Operational Guidelines of the Scheme for Promotion of Research and Innovation in Pharma MedTech (PRIP) Sector |
|
|
90 |
Corrigendum under PLI Scheme for Pharmaceuticals |
|
|
91 |
Operational Guidelines of the Scheme for Human Resource Development in Medical Device Sector |
|
|
92 |
Coffee Table Book On Indian Pharmaceuticals Industry |
|
|
93 |
Applications for the posts of Director of NIPER-Hyderabad and NIPER-Hajipur. |
|
|
94 |
Request for Proposal from CPSEs/Public Financial Institutions for as a Project Management Agency (PMA) for Promotion of Research and Innovation in Pharma and MedTech Sector (PRIP) Scheme |
|
|
95 |
14 सितम्बर, 2023 को हिन्दी दिवस के उपलक्ष्य में सचिव (औषध) का संदेश |
|
|
96 |
Hiring of 03 Consultants (Non-technical, Grade-II) in Department of Pharmaceuticals on contract basis -reg. |
|
|
97 |
Hiring of 06 Young Professionals in Department of Pharmaceuticals on contract basis -reg. |
|
|
98 |
Message from Honorable MoS (C&F) on Swachhta Pakhwada During 1-15 September 2023 |
|
|
99 |
Message from Honorable Minister (C&F) on Swachhta Pakhwada During 1-15 September 2023 |
|
|
100 |
Request for Proposal from CPSEs/Public Financial Institutions for providing services of Project Management Agency (PMA) for the Scheme (AMD-CF) |
|
औषध विभाग
Department of
